A Case Report of Dapagliflozin-Induced Nodular Vasculitis

被引:0
|
作者
Kocabas, Muhammet [1 ]
Yarar, Zeliha [1 ]
Cordan, Ilker [2 ]
Can, Mustafa [1 ]
Caliskan Burgucu, Hatice [1 ]
Aydemir, Harun [3 ]
Karakose, Melia [1 ]
Kulaksizoglu, Mustafa [1 ]
Karakurt, Feridun [1 ]
机构
[1] Necmettin Erbakan Univ, Meram Fac Med, Dept Endocrinol & Metab, Konya, Turkey
[2] Edirne Sultan 1 Murat State Hosp, Clin Endocrinol & Metab, Edirne, Turkey
[3] Necmettin Erbakan Univ, Meram Fac Med, Dept Rheumatol, Konya, Turkey
关键词
Nodular vasculitis; dapagliflozin; antinuclear antibodies; sodium-glucose cotransporter-2 inhibitors; diabetes mellitus; SGLT2; INHIBITORS; DIAGNOSIS;
D O I
10.25179/tjem.2020-80188
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodular vasculitis (NV), first described by Montgomery in 1945 for erythema induratum-like lesions, is a rare form of panniculitis that is particularly localized on the calves. Characterized by plaques and erythematous nodules, NV may often show ulceration and draining. It is known as a reactive disease associated with many causative factors. Several NV cases due to infectious or non-infectious causative factors have been reported, but no case of NV due to sodium-glucose cotransporter-2 inhibitors (SGLT2i) has yet been reported. In this case report, we presented a case diagnosed with NV, who presented with tender, erythematous, eroded plaques with hemorrhagic-purulent discharge on both legs during treatment with dapagliflozin (an SGLT2i).
引用
收藏
页码:129 / 132
页数:4
相关论文
共 50 条
  • [1] Dapagliflozin-Induced Acute Pancreatitis: A Case Report and Review of Literature
    Sujanani, Sunam M.
    Elfishawi, Mohanad M.
    Zarghamravanbaksh, Paria
    Castillo, Francisco J. Cuevas
    Reich, David M.
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [2] Dapagliflozin-Induced Cutaneous Vasculitis, a Hitherto Unreported Adverse Effect
    Bhattacharyya, Surjyamukhi
    Ghosh, Aparajita
    INDIAN JOURNAL OF DERMATOLOGY, 2024, 69 (04) : 355 - 357
  • [3] Dapagliflozin-induced hypercalcemia
    Marques Vidas, Maria
    Dura Gurpide, Beatriz
    Rubio, Esther
    Huerta, Ana
    Portoles Perez, Jose
    NEFROLOGIA, 2018, 38 (03): : 336 - 337
  • [4] Dapagliflozin-Induced Acute Pancreatitis: A Case Presentation and Review of the Literature
    Issa, Panagiota
    Agapakis, Dimitrios
    Machaira, Konstantina
    Ioannis, Karageorgiou
    Kotronis, Georgios
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [5] DAPAGLIFLOZIN-INDUCED ACUTE INTERSTITIAL NEPHRITIS
    Maknoord, Pooja
    Ortega, Javier A.
    Garrett, Matthew
    Goraya, Nimrit
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S33 - S33
  • [6] Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report
    Gong, Shikun
    Zhang, Shunan
    Ye, Yun
    Wu, Meiling
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (08)
  • [8] Dapagliflozin-Induced Acute-on-Chronic Liver Injury
    Levine, Joshua A.
    Lo, Amy Ann
    Wallia, Amisha
    Rogers, Melinda
    VanWagner, Lisa B.
    ACG CASE REPORTS JOURNAL, 2016, 3 (04)
  • [9] NOT TOO SWEET: DAPAGLIFLOZIN-INDUCED EUGLYCEMIC DIABETIC KETOACIDOSIS
    Andrade, Katherine
    Iqbal, Syed H.
    CHEST, 2022, 162 (04) : 973A - 973A
  • [10] Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case
    Cure, Erkan
    Sirin, Hakan
    Cure, Medine Cumhur
    Sahin, Dursun Ali
    INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (02) : 174 - 175